Sort   by:  
 Page size 
UnknownEffect of autoimmune comorbidities on multiple sclerosis course: An observational multicenter study.
Not available
S-EPMC11669769 | biostudies-literature
UnknownUser requirements for quantitative radiological reports in multiple sclerosis.
Not available
S-EPMC12417231 | biostudies-literature
UnknownComparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS.
Not available
S-EPMC12584038 | biostudies-literature
UnknownData monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register.
Not available
S-EPMC10264214 | biostudies-literature
UnknownDisease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.
Not available
S-EPMC8013440 | biostudies-literature
UnknownDo patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.
Not available
S-EPMC9385759 | biostudies-literature
UnknownThe effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis.
Not available
S-EPMC8652772 | biostudies-literature
UnknownDMTs and Covid-19 severity in MS: a pooled analysis from Italy and France.
Not available
S-EPMC8351392 | biostudies-literature
UnknownTocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Not available
S-EPMC7576974 | biostudies-literature
Sort   by:  
 Page size